Type I Interferons in Autoimmune Disease von Crow, Mary K, Olferiev, Mikhail, Kirou, Kyriakos A

Volltext

Targeting of type I interferon in systemic autoimmune diseases von Crow, Mary K, Olferiev, Mikhail, Kirou, Kyriakos A

Volltext

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment von Kirou, Kyriakos A, Dall Era, Maria, Aranow, Cynthia, Anders, Hans-Joachim

Volltext

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial von Spiera, Robert F, Gordon, Jessica K, Mersten, Jamie N, Magro, Cynthia M, Mehta, Mansi, Wildman, Horatio F, Kloiber, Stacey, Kirou, Kyriakos A, Lyman, Stephen, Crow, Mary K

Volltext

Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps von Dwivedi, Nishant, Upadhyay, Jagriti, Neeli, Indira, Khan, Salar, Pattanaik, Debendra, Myers, Linda, Kirou, Kyriakos A., Hellmich, Bernhard, Knuckley, Bryan, Thompson, Paul R., Crow, Mary K., Mikuls, Ted R., Csernok, Elena, Radic, Marko

Volltext

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients von Thurlings, Rogier M., Boumans, Marie, Tekstra, Janneke, van Roon, Joel A., Vos, Koen, van Westing, Daisy Marie, van Baarsen, Lisa G., Bos, Carina, Kirou, Kyriakos A., Gerlag, Danielle M., Crow, Mary K., Bijlsma, Johannes W., Verweij, Cornelis L., Tak, Paul P.

Volltext

Anti-interferon alpha treatment in SLE von Kirou, Kyriakos A, Gkrouzman, Elena

Volltext

Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment von Crow, Mary K., Olferiev, Mikhail, Kirou, Kyriakos A.

Volltext

Microarray Analysis of Interferon-regulated Genes in SLE von Crow, Mary K., Kirou, Kyriakos A., Wohlgemuth, Jay

Volltext

What Causes Lupus Flares? von Fernandez, David, Kirou, Kyriakos A.

Volltext

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease von Mavragani, Clio P., Sagalovskiy, Irina, Guo, Qiu, Nezos, Adrianos, Kapsogeorgou, Efstathia K., Lu, Pin, Liang Zhou, Jun, Kirou, Kyriakos A., Seshan, Surya V., Moutsopoulos, Haralampos M., Crow, Mary K.

Volltext

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations von Mavragani, Clio P, Kirou, Kyriakos A, Seshan, Surya V, Crow, Mary K

Volltext

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares von Zisa, Diane, Zhang-Sun, Jeffrey, Christos, Paul J, Kirou, Kyriakos A

Volltext

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes von Mavragani, Clio P., Nezos, Adrianos, Sagalovskiy, Irina, Seshan, Surya, Kirou, Kyriakos A., Crow, Mary K.

Volltext

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis von Atisha‐Fregoso, Yemil, Malkiel, Susan, Harris, Kristina M., Byron, Margie, Ding, Linna, Kanaparthi, Sai, Barry, William T., Gao, Wendy, Ryker, Kristin, Tosta, Patti, Askanase, Anca D., Boackle, Susan A., Chatham, W. Winn, Kamen, Diane L., Karp, David R., Kirou, Kyriakos A., Sam Lim, S., Marder, Bradley, McMahon, Maureen, Parikh, Samir V., Pendergraft, William F., Podoll, Amber S., Saxena, Amit, Wofsy, David, Diamond, Betty, Smilek, Dawn E., Aranow, Cynthia, Dall’Era, Maria

Volltext

Low Peripheral B-Cell Counts in Patients With Systemic Rheumatic Diseases Due to Treatment With Belimumab and/or Rituximab Are Associated With Low Antibody Responses to Primary COV... von Zhang-Sun, Jeffrey, Kirou, Raphael A., Kirou, Kyriakos A.

Volltext

Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients von Gkrouzman, Elena, Peng, Mary, Davis‐Porada, Julia, Kirou, Kyriakos A.

Volltext

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses von Chaudhary, Vidyanath, Ah Kioon, Marie Dominique, Hwang, Sung-Min, Mishra, Bikash, Lakin, Kimberly, Kirou, Kyriakos A, Zhang-Sun, Jeffrey, Wiseman, R Luke, Spiera, Robert F, Crow, Mary K, Gordon, Jessica K, Cubillos-Ruiz, Juan R, Barrat, Franck J

Volltext

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind rand... von Merrill, Joan T, Wallace, Daniel J, Petri, Michelle, Kirou, Kyriakos A, Yao, Yihong, White, Wendy I, Robbie, Gabriel, Levin, Robert, Berney, Seth M, Chindalore, Vishala, Olsen, Nancy, Richman, Laura, Le, Chenxiong, Jallal, Bahija, White, Barbara

Volltext

308 Transcriptional profiles associated with pericarditis in patients with systemic lupus erythematosus (SLE) identify purine metabolism pathway genes as candidate mediators von Mikhail, Olferiev, Madison, Drogy, David, Fernandez, Kirou Kyriakos, A, Crow Mary, K

Volltext